研發(fā)與技術(shù)
R&D and Technology
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
2022-08-30
999+
學(xué)術(shù)論著
上一篇：Immunogenicity correlation in cynomolgus monkeys between Luminex‐d total IgG immunoassay and pseudovirion‐ d neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
下一篇：Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second line therapy in advanced esophageal squamous cell cancer
最新資訊
-
2024-SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma A randomized phase 3 trial
2024-06-20 -
2024-Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters
2024-05-06 -
2024-Immunogenicity of Tetravalent Protein Vaccine against SARS-CoV-2 EG.5 Subvaraint A Phase 2 Trial
2024-02-08 -
2024-Finotonlimab with chemotherapy in recurrent or static head and neck cancer a randomized phase 3 trial
2024-06-02